ESR1 and cancer: The estrogen-ERα signal activates the JAK2/STAT3 pathway, driving the differentiation of bone marrow myeloid precursors into Myeloid-Derived Suppressor Cells, enhancing their immunosuppressive function, thereby inhibiting the anti-tumor T-cell response and accelerating cancer progression (62).